Cargando…
Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease
Prevention of bone fractures is one goal of therapy for patients with chronic kidney disease-mineral and bone disorder (CKD-MBD), as indicated by the Kidney Disease: Improving Global Outcomes guidelines. CKD patients, including those on hemodialysis, are at higher risk for fractures and fracture-rel...
Autores principales: | Iwasaki, Yoshiko, Kazama, Junichiro James, Fukagawa, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380833/ https://www.ncbi.nlm.nih.gov/pubmed/28421193 http://dx.doi.org/10.1155/2017/3485785 |
Ejemplares similares
-
Chronic kidney disease and fragility fracture
por: Kazama, Junichiro James
Publicado: (2016) -
TGF-Beta Signaling in Bone with Chronic Kidney Disease
por: Iwasaki, Yoshiko, et al.
Publicado: (2018) -
Uremic osteoporosis
por: Kazama, Junichiro J, et al.
Publicado: (2013) -
Bone fragility in patients with chronic kidney disease
por: Cohen-Solal, Martine, et al.
Publicado: (2020) -
Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
por: Goto, Shunsuke, et al.
Publicado: (2013)